Cyanosis laboratory findings: Difference between revisions
No edit summary |
|||
| (2 intermediate revisions by one other user not shown) | |||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Laboratory findings consistent with the diagnosis of [[central cyanosis]] include | Laboratory findings consistent with the diagnosis of [[central cyanosis]] include [[Polycythemia]] due to secondary [[erythrocytosis]], Elevated [[prothrombin time]] and [[partial thromboplastin time]] , decreased levels of factors 5,7,8,9 (qualitative and quantitative),[[Platelet disorder]], increased [[fibrinolysis]] and paradoxical [[thrombotic]] tendency, [[Proteinuria]], [[Hyperuricemia]], [[Renal failure]] and [[nephrolithiasis]]. | ||
==Laboratory Findings== | ==Laboratory Findings== | ||
| Line 22: | Line 22: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Primary care]] | |||
[[Category: | |||
Latest revision as of 04:17, 26 December 2020
|
Cyanosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cyanosis laboratory findings On the Web |
|
American Roentgen Ray Society Images of Cyanosis laboratory findings |
|
Risk calculators and risk factors for Cyanosis laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Amandeep Singh M.D.[3]
Overview
Laboratory findings consistent with the diagnosis of central cyanosis include Polycythemia due to secondary erythrocytosis, Elevated prothrombin time and partial thromboplastin time , decreased levels of factors 5,7,8,9 (qualitative and quantitative),Platelet disorder, increased fibrinolysis and paradoxical thrombotic tendency, Proteinuria, Hyperuricemia, Renal failure and nephrolithiasis.
Laboratory Findings
- Polycythemia due to secondary erythrocytosis
- Elevated prothrombin time and partial thromboplastin time
- Decreased levels of factors 5,7,8,9: qualitative and quantitative
- Platelet disorder
- Increased fibrinolysis and paradoxical thrombotic tendency
- Proteinuria
- Hyperuricemia
- Renal failure
- Uric acid nephrolithiasis
References
- ↑ Bhardwaj V, Malhotra P, Hasija S, Chowdury UK, Pangasa N (2017). "Coagulopathies in cyanotic cardiac patients: An analysis with three point - of - care testing devices (Thromboelastography, rotational thromboelastometry, and sonoclot analyzer)". Ann Card Anaesth. 20 (2): 212–218. doi:10.4103/aca.ACA_4_17. PMC 5408528. PMID 28393783.